Stalevo: Clinical Trials

6 trials of Stalevo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 16Completed 6

Follow Stalevo: new trials by email Literature Review of Stalevo trials Research Report on Stalevo

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetic Study in Healthy Volunteers
levodopa, carbidopa, ODM-104, levodopa, carbidopa, entacapone - Parkinson's Disease
Phase 1CompletedOrion Corporation, Orion Pharma152015-08-012016-01-14
Levodopa Concentration Profile With Stalevo 75/125 mg
Stalevo (levodopa/ carbidopa/ entacapone), Sinemet (levodopa/carbidopa) - Parkinson's Disease
Phase 1CompletedOrion Corporation, Orion Pharma202009-12-012010-08-13
Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
ELC200 (carbidopa+levodopa+entacapone) - Healthy
Phase 1CompletedNovartis422006-07-012007-06-22
Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers
ELC200 (carbidopa+levodopa+entacapone) - Healthy
Phase 1CompletedNovartis422006-06-012007-06-22
Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
ELC200 (carbidopa+levodopa+entacapone) - Healthy
Phase 1CompletedNovartis422006-06-012007-06-22
Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
ELC200 (carbidopa+levodopa+entacapone) - Healthy
Phase 1CompletedNovartis422006-05-012007-06-22

Conditions studied

Parkinson Disease (2)  ·  Fasting (1)

Sponsors

Novartis (4)  ·  Orion Corporation, Orion Pharma (2)

Countries

Germany (4)  ·  Finland (2)

Top investigators

Kimmo Ingman (1)  ·  Mika Scheinin, MD (1)